556112-92-6

Basic information

• Product Name: methyl 2-fluoro-5-(trifluoromethyl)benzenecarboxylate
• Synonyms: methyl 2-fluoro-5-(trifluoromethyl)benzenecarboxylate;3-(Ethoxycarbonyl)-4-fluorobenzotrifluoride;Mthyl 2-fluoro-5-(trifluoromethyl)benzoate;Methyl 2-fluoro-5-(trifluoromethyl)
• CAS NO: 556112-92-6
• Molecular Formula: C9H6F4O2
• Molecular Weight: 222
• Mol File: 556112-92-6.mol
• Article Data: 4

Chemical Properties

• Boiling Point: 216.4±40.0 °C(Predicted)
• Appearance: /
• Density: 1.345±0.06 g/cm3(Predicted)
• Storage Temp.: Sealed in dry,Room Temperature
• CAS DataBase Reference: methyl 2-fluoro-5-(trifluoromethyl)benzenecarboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: methyl 2-fluoro-5-(trifluoromethyl)benzenecarboxylate(556112-92-6)
• EPA Substance Registry System: methyl 2-fluoro-5-(trifluoromethyl)benzenecarboxylate(556112-92-6)

Safety Data

• HazardClass: IRRITANT
• Hazardous Substances Data: 556112-92-6(Hazardous Substances Data)

Usage

General Description

Methyl 2-fluoro-5-(trifluoromethyl)benzenecarboxylate is a chemical compound with the molecular formula C10H6F4O2. It is a colorless liquid that is commonly used in the pharmaceutical and agricultural industries as a building block in the synthesis of various drugs and pesticides. methyl 2-fluoro-5-(trifluoromethyl)benzenecarboxylate is known for its strong aromatic and ester-like odor. It is also used in the production of perfumes and flavors. Due to its highly reactive nature, it requires careful handling and storage to prevent accidental exposure or contamination.

InChI:InChI=1S/C9H6F4O2/c1-15-8(14)6-4-5(9(11,12)13)2-3-7(6)10/h2-4H,1H3

Upstream product

• 115029-23-7 2-fluoro-5-(trifluoromethyl)benzoic acid 
• 74-88-4 methyl iodide 
• 67-56-1 methanol 

Relevant articles and documents

INDOLE DERIVATIVE USED AS CRTH2 INHIBITOR

The present application discloses an indole as represented by formula (I) used as a CRTH2 inhibitor, and a pharmaceutically acceptable salt or tautomer of the indole, and an application of same in treating a disease related to a CRTH2 receptor.

SUBSTITUTED PHENOXY THIAZOLIDINEDIONES AS ESTROGEN RELATED RECEPTOR-ALPHA MODULATORS

The present invention relates to compounds of Formula (I): methods for preparing these compounds, compositions, intermediates and derivatives thereof and for treating a condition including but not limited to ankylosing spondylitis, artherosclerosis, arthritis (such as rheumatoid arthritis, infectious arthritis, childhood arthritis, psoriatic arthritis, reactive arthritis), bone-related diseases (including those related to bone formation), breast cancer (including those unresponsive to anti-estrogen therapy), cardiovascular disorders, cartilage-related disease (such as cartilage injury/loss, cartilage degeneration, and those related to cartilage formation), chondrodysplasia, chondrosarcoma, chronic back injury, chronic bronchitis, chronic inflammatory airway disease, chronic obstructive pulmonary disease, diabetes, disorders of energy homeostasis, gout, pseudogout, lipid disorders, metabolic syndrome, multiple myeloma, obesity, osteoarthritis, osteogenesis imperfecta, osteolytic bone metastasis, osteomalacia, osteoporosis, Paget's disease, periodontal disease, polymyalgia rheumatica, Reiter's syndrome, repetitive stress injury, hyperglycemia, elevated blood glucose level, and insulin resistance.